See Local News
Get Balanced News From Your U.S. State.
See Local News
See all locals

Merck to buy Prometheus Biosciences for about $11 billion

Posted on AllSides April 16th, 2023
From The Center
REUTERS/Andrew Kelly

Merck & Co (MRK.N) has agreed to acquire Prometheus Biosciences Inc (RXDX.O) for about $10.8 billion to bolster the company's presence in immunology, the companies said on Sunday.

The joint statement said that Merck, through one of its subsidiaries, will pay $200 per share for the biotechnology company that specializes in products for treatment of immunological diseases. That represents a 75% premium to the $114.01 closing price for Prometheus shares on Friday.

Read full story

AllSides Picks

https://www.reuters.com/markets/deals/merck-late-stage-talks-acquire-prometheus-biosciences-wsj-2023-04-16/

More News about Economy and Jobs from the Left, Center and Right

From the Left

From the Center

From the Right